Already the go-to drug of choice for millions with type 2 diabetes, metformin might also fight lung cancer if those patients ...

A widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and ...

1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. 2Department of Immunology, Harvard Medical School, Boston, Massachusetts. 3Department of Neurology, ...

Metformin, a common diabetes drug, shows promise in enhancing lung cancer treatment for overweight patients, according to new research. The study reveals that metformin boosts the effects of ...

Some patients being treated with immune ... no evidence for T-cell receptors recognizing the α-myosin protein, which was previously reported to be a pivotal antigen driving checkpoint myocarditis.

Researchers unveil method to map immune cell connections, predicting patient survival in cancer Researchers developed a combination of imaging and computational methods to study connections ...

Immune checkpoint inhibitors are used in metastatic triple-negative breast ... Those with metabolic syndrome (obesity, type 2 diabetes and high blood pressure) are also at risk. Obesity promotes the ...

In the past few years, immunotherapy, mainly immune checkpoint inhibitors (ICIs), has revolutionized the clinical strategy ... This review describes the immunosuppressive cell populations in the ...

Ryan Teague, Ph.D., professor of molecular microbiology and immunology at SLU, and his team are exploring why obesity impacts T-cell dysfunction and compromises immune surveillance, or the body ...